Premenstrual disorders including premenstrual syndrome and premenstrual dysphoric disorder

Abstract

The spectrum of premenstrual disorders is related to hormonal changes in the menstrual cycle and are experienced by nearly 40% of women. Approximately 3–8% of women are affected by severe premenstrual syndrome, including premenstrual dysphoric disorder (PMDD); a chronic, debilitating disorder with severe emotional and physical symptoms and functional impairment. PMDD significantly affects women's quality of life; recent evidence suggests that 86% of patients have considered suicide, with 30% having attempted suicide at least once. In 2019, PMDD was added to the International Statistical Classification of Diseases and Related Health Problems, (ICD–11), which validates PMDD as a legitimate diagnosis and acknowledges growing scientific and medical understanding of this previously under recognised condition. Symptom relief can often be achieved through medical management, therefore it is important to increase awareness among healthcare professionals at all levels.